Assignee
ESPERVITA THERAPEUTICS INC
US·8 granted patents·3 pending applications·25 citations·filing 2020–2025
Top patents by PatentIndex Score
11 records- 0197US11267778B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Granted Mar 8, 2022·6 cites·2 claims
- 0297US11098002B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2020·Granted Aug 24, 2021·5 cites·1 claims
- 0397US11084773B1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Granted Aug 10, 2021·5 cites·1 claims
- 0496US12252467B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·1 cites·16 claims
- 0595US12180151B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·1 cites·4 claims
- 0695US11730712B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Granted Aug 22, 2023·3 cites·21 claims
- 0789US11737995B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·4 cites·20 claims
- 0882US2023007838A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0980US2025367149A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1077US2022402851A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1174US12396972B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2023·Granted Aug 26, 2025·0 cites·3 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →